Key Insights

Highlights

Treatment Research

1 treatments under study, led by Alpha Lipoic Acid

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT01880372Not ApplicableTerminatedPrimary

The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic Retinopathy

NCT01790945Unknown

Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography

Showing all 2 trials

Research Network

Common Treatments

  • Alpha Lipoic Acid1

Active Sponsors

  • Retina Institute of Hawaii1
  • Ferris State University1
  • Retina Specialists of Michigan1

Top Investigators

Related Conditions

  • Diabetic Macular Edema1
  • Proliferative Diabetic Retinopathy1
  • Severe Nonproliferative Diabetic Retinopathy1
  • Mild Nonproliferative Diabetic Retinopathy1

Activity Timeline